Melphalan pharmacokinetics in children with malignant disease: influence of body weight, renal function, carboplatin therapy and total body irradiation

Por Nath, Christa E, Shaw, Peter J, Montgomery, Kay, Earl, John W
Publicado em 2005

Population pharmacokinetics of melphalan in paediatric blood or marrow transplant recipients

Por Nath, Christa E, Shaw, Peter J, Montgomery, Kay, Earl, John W
Publicado em 2007

Variability in the pharmacokinetics of intravenous busulphan given as a single daily dose to paediatric blood or marrow transplant recipients

Por Nath, Christa E, Earl, John W, Pati, Nalini, Stephen, Katherine, Shaw, Peter J
Publicado em 2008

Amphotericin B in Children with Malignant Disease: a Comparison of the Toxicities and Pharmacokinetics of Amphotericin B Administered in Dextrose versus Lipid Emulsion

Por Nath, Christa E., Shaw, Peter J., Gunning, Robyn, McLachlan, Andrew J., Earl, John W.
Publicado em 1999

Population pharmacokinetics of amphotericin B in children with malignant diseases

Por Nath, Christa E, McLachlan, Andrew J, Shaw, Peter J, Gunning, Robyn, Earl, John W
Publicado em 2001

Population Pharmacokinetics of Liposomal Amphotericin B in Pediatric Patients with Malignant Diseases

Por Hong, Ying, Shaw, Peter J., Nath, Christa E., Yadav, Satya P., Stephen, Katherine R., Earl, John W., McLachlan, Andrew J.
Publicado em 2006

HeLa cells cocultured with peripheral blood lymphocytes acquire an immuno-inhibitory phenotype through up-regulation of indoleamine 2,3-dioxygenase activity

Por Logan, Grant J, Smyth, Christine M F, Earl, John W, Zaikina, Irina, Rowe, Peter B, Smythe, Jason A, Alexander, Ian E
Publicado em 2002

Population pharmacokinetics of mycophenolic acid in children and young people undergoing blood or marrow and solid organ transplantation

Por Zeng, Lihua, Blair, Elaine Y L, Nath, Christa E, Shaw, Peter J, Earl, John W, Stephen, Katherine, Montgomery, Kay, Coakley, John C, Hodson, Elisabeth, Stormon, Michael, McLachlan, Andrew J
Publicado em 2010

High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation

Por Nath, Christa E., Trotman, Judith, Tiley, Campbell, Presgrave, Peter, Joshua, Douglas, Kerridge, Ian, Kwan, Yiu Lam, Gurney, Howard, McLachlan, Andrew J., Earl, John W., Nivison‐Smith, Ian, Zeng, Lihua, Shaw, Peter J.
Publicado no Br J Clin Pharmacol (2016)